• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
PRPH

PRPH

ProPhase Labs, Inc.

NASDAQHealthcareDrug Manufacturers - Specialty & GenericUS

USD0.14

+0.00 (+0.00%)

Rating:D+

Company Profile

CEO

Ted William Karkus

IPO Date

1994-04-04

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

Country

US

Market Metrics

Open

$0.14

Prev. Close

$0.14

Day Low

$0.14

Day High

$0.15

52W Low

$0.07

52W High

$6.70

Market Cap

$0.00B

Volume

0.02M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

36.3%

Avg Negative

2.6%

Avg Neutral

61.3%

News Feed

ProPhase Labs to Present at the Access to Giving Virtual Investor Conference on July 15, 2021

GlobeNewsWire·7/12/2021·↑ positive

ProPhase Labs Diversifies with Formation of Genomics and Global Healthcare Subsidiaries

GlobeNewsWire·6/10/2021·↑ positive

ProPhase Labs to Present at LD Micro Invitational XI Virtual Conference

GlobeNewsWire
·5/28/2021
·↓ negative

ProPhase Labs' (PRPH) CEO Ted Karkus on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/13/2021·↓ negative

PRPH Stock: 14.94% Increase (From $5.22 To $6) Pre-Market Explanation

Pulse2·5/6/2021·↑ positive

ProPhase Labs to Host First Quarter 2021 Financial Results Conference Call on Thursday, May 13, 2021 at 4:30 p.m. Eastern Time

GlobeNewsWire·4/15/2021·↓ negative

ProPhase Labs, Inc. (PRPH) CEO Ted Karkus on Q4 2020 Results - Earnings Call Transcript

Seeking Alpha·3/31/2021·↓ negative

ProPhase Labs Reports Fourth Quarter and Full Year 2020 Financial Results

GlobeNewsWire·3/31/2021·↑ positive

PRPH Stock Price Increased Over 10% Pre-Market: Why It Happened

Pulse2·3/31/2021·↑ positive

ProPhase Labs Acquires Digital Covid Vaccination and Testing “Passport” Solution

GlobeNewsWire·3/30/2021·↑ positive